StonvexLoading…
StonvexStonvexStonvexCore line items from APH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.62B | $23.09B | $16.66B | $10.46B |
Operating Income | $1.83B | $5.87B | $4.15B | $2.44B |
Net Income | $933.00M | $4.27B | $3.07B | $1.83B |
EPS (Diluted) | $0.72 | $3.34 | $2.41 | $1.44 |
Total Assets | $42.13B | $36.24B | $27.14B | $25.67B |
Total Liabilities | $28.04B | $22.73B | $14.54B | $14.07B |
Cash & Equivalents | $4.13B | $11.13B | $3.80B | $3.21B |
Free Cash Flow OCF − CapEx | $829.90M | $4.38B | $2.91B | $1.70B |
Shares Outstanding | 1.29B | 1.23B | 1.27B | 1.27B |